Zymeworks, Inc. (ZYME)
25.85
-0.12
(-0.46%)
USD |
NASDAQ |
Dec 16, 16:00
25.85
0.00 (0.00%)
After-Hours: 16:49
Zymeworks Research and Development Expense (Annual): 134.62M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Jazz Pharmaceuticals Plc | 884.00M |
| Johnson & Johnson | 17.26B |
| Regeneron Pharmaceuticals, Inc. | 4.624B |
| Vertex Pharmaceuticals, Inc. | 3.630B |
| CorMedix, Inc. | 3.942M |